Noxopharm (NOX: ASX) today releases an updated corporate presentation ahead of non-deal roadshow presentations planned over the coming month in the U.S., Hong Kong and China. This is part of the Company’s efforts to raise its profile in the global investment community ahead of planned release of key clinical data over the next 5 months.
To view the presentation, download the attached PDF.
Download this document
